Biomarkers of exposure and effect in the lungs of smokers, nonsmokers, and electronic cigarette users A C

Cancer Epidemiology Biomarkers and Prevention

Volumn 29, Issue 2, 2020, Pages 443-451

  Song, Min Ae ^a,b   Freudenheim, Jo L ^c   Brasky, Theodore M ^a   Mathe, Ewy A ^a   McElroy, Joseph P ^a   Nickerson, Quentin A ^a   Reisinger, Sarah A ^a   Smiraglia, Dominic J ^d   Weng, Daniel Y ^a   Ying, Kevin L ^a,b   Wewers, Mark D ^b   Shields, Peter G ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABHK4 PROTEIN; AHRR PROTEIN; AMZ1 PROTEIN; AROMATIC HYDROCARBON RECEPTOR; BIOLOGICAL MARKER; GAMMA INTERFERON; HYPOXIA INDUCIBLE FACTOR 1BETA; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; KRT12 PROTEIN; LINC00589 PROTEIN; MIC5AC PROTEIN; MUCIN 5B; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 3; PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 5; REEP1 PROTEIN; RHBDL2 PROTEIN; TMPRSS3 PROTEIN; TRANSCRIPTION FACTOR NRF1; TTC16 PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; ZNF445 PROTEIN; ZNF815 PROTEIN; CYTOKINE;

ACUTE LUNG INJURY; ADULT; ARTICLE; BIOLOGICAL ACTIVITY; BRONCHOSCOPY; BRONCHUS BIOPSY; CAUSE OF DEATH; CELL COUNT; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENOME-WIDE ASSOCIATION STUDY; HUMAN; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NON-SMOKER; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; XENOBIOTIC METABOLISM; ADVERSE EVENT; BRONCHOALVEOLAR LAVAGE FLUID; COMPARATIVE STUDY; CYTOLOGY; DIAGNOSTIC IMAGING; ELECTRONIC CIGARETTE; GENE EXPRESSION PROFILING; IMMUNOLOGY; LUNG; METABOLISM; PATHOLOGY; SMOKING; YOUNG ADULT;

ADULT; BIOMARKERS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CELL COUNT; CIGARETTE SMOKING; CYTOKINES; DNA METHYLATION; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LUNG; MALE; NON-SMOKERS; SMOKERS; YOUNG ADULT;

EID: 85079075059     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-19-1245     Document Type: Article

References (49)

1. National Academies of Sciences, Engineering, and Medicine. Public health consequences of e-cigarettes. Washington (DC): National Academies Press; 2018.
2. Halpern SD, Harhay MO, Saulsgiver K, Brophy C, Troxel AB, Volpp KG. A pragmatic trial of e-cigarettes, incentives, and drugs for smoking cessation. N Engl J Med 2018;378:2302-10.
3. Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, Bisal N, et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med 2019;380:629-37.
4. Kalkhoran S, Glantz SA. E-cigarettes and smoking cessation in real-world and clinical settings: a systematic review andmeta-analysis. Lancet Respir Med 2016; 4:116-28.
5. Butt YM, Smith ML, Tazelaar HD, Vaszar LT, Swanson KL, Cecchini MJ, et al. Pathology of vaping-associated lung injury. N Engl J Med 2019;381:1780-1.
6. Davidson K, Brancato A, Heetderks P, Mansour W, Matheis E, Nario M, et al. Outbreak of electronic-cigarette-associated acute lipoid pneumonia - North Carolina, July-August 2019. MMWR Morb Mortal Wkly Rep 2019;68:784-6.
7. Maddock SD, Cirulis MM, Callahan SJ, Keenan LM, Pirozzi CS, Raman SM, et al. Pulmonary lipid-laden macrophages and vaping. N Engl J Med 2019; 381:1488-9.
8. Layden JE, Ghinai I, Pray I, Kimball A, Layer M, Tenforde M, et al. Pulmonary illness related to e-cigarette use in Illinois and Wisconsin-preliminary report. N Engl J Med 2019 Sep 6 [Epub ahead of print] .
9. Shields PG, Berman M, Brasky TM, Freudenheim JL,Mathe E,McElroy JP, et al. A review of pulmonary toxicity of electronic cigarettes in the context of smoking: a focus on inflammation. Cancer Epidemiol Biomarkers Prev 2017;26:1175-91.
10. Husari A, Shihadeh A, Talih S, Hashem Y, El Sabban M, Zaatari G. Acute exposure to electronic and combustible cigarette aerosols: effects in an animal model and in human alveolar cells. Nicotine Tob Res 2016;18:613-9.
11. Goniewicz ML, Smith DM, Edwards KC, Blount BC, Caldwell KL, Feng J, et al. Comparison of nicotine and toxicant exposure in users of electronic cigarettes and combustible cigarettes. JAMA Netw Open 2018;1:e185937.
12. Landmesser A, Scherer M, Pluym N, Sarkar M, Edmiston J, Niessner R, et al. Biomarkers of exposure specific to E-vapor products based on stable-isotope labeled ingredients. Nicotine Tob Res 2019;21:314-22.
13. Lorkiewicz P, Riggs DW,Keith RJ,Conklin DJ, Xie Z, Sutaria S, et al. Comparison of urinary biomarkers of exposure in humans using electronic cigarettes, combustible cigarettes, and smokeless tobacco. Nicotine Tob Res 2019;21: 1228-38.
14. Reidel B, Radicioni G, Clapp P, Ford AA, Abdelwahab S, Rebuli ME, et al. Ecigarette use causes a unique innate immune response in the lung involving increased neutrophilic activation and altered mucin secretion. Am J Respir Crit Care Med 2018;197:492-501.
15. Polosa R, Cibella F, Caponnetto P,Maglia M, Prosperini U, Russo C, et al. Health impact of E-cigarettes: a prospective 3.5-year study of regular daily users who have never smoked. Sci Rep 2017;7:13825.
16. Ghosh A, Coakley RC, Mascenik T, Rowell TR, Davis ES, Rogers K, et al. Chronic e-cigarette exposure alters the human bronchial epithelial proteome.AmJ Respir Crit Care Med 2018;198:67-76.
17. Staudt MR, Salit J, Kaner RJ, Hollmann C, Crystal RG. Altered lung biology of healthy never-smokers following acute inhalation of E-cigarettes. Respir Res 2018;19:78.
18. Ghosh A, Coakley RD, Ghio AJ, Muhlebach MS, Esther CR Jr, Alexis NE, et al. Chronic e-cigarette use increases neutrophil elastase and matrix metalloprotease levels in the lung. Am J Respir Crit Care Med 2019;200:1392-401.
19. Tsai M, Song MA, McAndrew C, Brasky TM, Freudenheim JL, Mathe E, et al. Electronic vs combustible cigarette effects on inflammasome component release into human lung. Am J Respir Crit Care Med 2019;199:922-5.
20. Maksimovic J, Gordon L, Oshlack A. SWAN: Subset-quantile Within Array Normalization for Illumina Infinium HumanMethylation450 BeadChips. Genome Biol 2012;13:R44.
21. Moran S, Arribas C, EstellerM. Validation of a DNAmethylationmicroarray for 850,000 CpG sites of the human genome enriched in enhancer sequences. Epigenomics 2016;8:389-99.
22. McCartney DL, Walker RM, Morris SW,McIntosh AM, Porteous DJ, Evans KL. Identification of polymorphic and off-target probe binding sites on the Illumina Infinium MethylationEPIC BeadChip. Genomics Data 2016;9:22-4.
23. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B 1995;57:289-300.
24. Quackenbush J. Computational analysis of microarray data.Nat RevGenet 2001; 2:418-27.
25. Abdi H, Williams LJ. Principal component analysis. WIREs Comp Stat 2010;2: 433-59. doi: 10.1002/wics.101.
26. Etter JF. Electronic cigarettes: a survey of users. BMC Public Health 2010;10:231.
27. Behar RZ, Hua M, Talbot P. Puffing topography and nicotine intake of electronic cigarette users. PLoS One 2015;10:e0117222.
28. Bhavani S, Tsai CL, Perusich S, Hesselbacher S, Coxson H, Pandit L, et al. Clinical and immunological factors in emphysema progression. Five-year prospective Longitudinal Exacerbation Study of Chronic Obstructive Pulmonary Disease (LES-COPD). Am J Respir Crit Care Med 2015;192:1171-8.
29. Brenner DR, Fanidi A, Grankvist K, Muller DC, Brennan P, Manjer J, et al. Inflammatory cytokines and lung cancer risk in 3 prospective studies. Am J Epidemiol 2017;185:86-95.
30. Strulovici-Barel Y, Omberg L, O'Mahony M, Gordon C, Hollmann C, Tilley AE, et al. Threshold of biologic responses of the small airway epithelium to low levels of tobacco smoke. Am J Respir Crit Care Med 2010;182:1524-32.
31. Whitney DH, Elashoff MR, Porta-Smith K, Gower AC, Vachani A, Ferguson JS, et al. Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy. BMC Med Genomics 2015;8:18.
32. Vachani A, Whitney DH, Parsons EC, Lenburg M, Ferguson JS, Silvestri GA, et al. Clinical utility of a bronchial genomic classifier in patients with suspected lung cancer. Chest 2016;150:210-8.
33. Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 2017;377:1119-31.
34. Yao X, Huang J, Zhong H, Shen N, Faggioni R, Fung M, et al. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacol Ther 2014;141:125-39.
35. DeCotiis C, Hu Y, Greenberg AK, Huie M, Tsay JC, Pass H, et al. Inflammatory cytokines and non-small cell lung cancer in a CT-scan screening cohort: background review of the literature. Cancer Biomark 2016;16:219-33.
36. Bradford E, Jacobson S, Varasteh J, Comellas AP, Woodruff P, O'Neal W, et al. The value of blood cytokines and chemokines in assessing COPD. Respir Res 2017;18:180.
37. Reynolds CJ, Quigley K, Cheng X, Suresh A, Tahir S,Ahmed-Jushuf F, et al. Lung defense through IL-8 carries a cost of chronic lung remodeling and impaired function. Am J Respir Cell Mol Biol 2018;59:557-71.
38. Chang JT, Chang H, Chen PH, Lin SL, Lin P. Requirement of aryl hydrocarbon receptor overexpression for CYP1B1 up-regulation and cell growth in human lung adenocarcinomas. Clin Cancer Res 2007;13:38-45.
39. Helmig S, Seelinger JU, Philipp-Gehlhaar M, Dohrel J, Schneider J. Cyp1B1 mRNA expression in correlation to cotinine levels with respect to the Cyp1B1 L432V gene polymorphism. Eur J Epidemiol 2010;25:867-73.
40. Shiizaki K, Kawanishi M, Yagi T. Modulation of benzo[a] pyrene-DNA adduct formation by CYP1 inducer and inhibitor. Genes Environ 2017;39:14.
41. Ma Y, Li MD. Establishment of a strong link between smoking and cancer pathogenesis through DNA methylation analysis. Sci Rep 2017;7: 1811.
42. Gao X, Jia M, Zhang Y, Breitling LP, Brenner H. DNA methylation changes of whole blood cells in response to active smoking exposure in adults: a systematic review of DNA methylation studies. Clin Epigenetics 2015;7:113.
43. Tsay JJ, Tchou-Wong KM, Greenberg AK, Pass H, Rom WN. Aryl hydrocarbon receptor and lung cancer. Anticancer Res 2013;33:1247-56.
44. Kitamura H,Motohashi H. NRF2 addiction in cancer cells. Cancer Sci 2018;109: 900-11.
45. Cho HY, Kleeberger SR. Association of Nrf2 with airway pathogenesis: lessons learned from genetic mouse models. Arch Toxicol 2015;89:1931-57.
46. Battino M, Giampieri F, Pistollato F, Sureda A, de Oliveira MR, Pittala V, et al. Nrf2 as regulator of innate immunity: a molecular Swiss army knife! Biotechnol Adv 2018;36:358-70.
47. Smutny T, Mani S, Pavek P. Post-translational and post-transcriptional modifications of pregnane X receptor (PXR) in regulation of the cytochrome P450 superfamily. Curr Drug Metab 2013;14:1059-69.
48. Lee SM, Lee JY, Choi JE, Lee SY, Park JY, Kim DS. Epigenetic inactivation of retinoid X receptor genes in non-small cell lung cancer and the relationship with clinicopathologic features. Cancer Genet Cytogenet 2010;197:39-45.
49. Madison MC, Landers CT, Gu BH, Chang CY, Tung HY, You R, et al. Electronic cigarettes disrupt lung lipid homeostasis and innate immunity independent of nicotine. J Clin Invest 2019;129:4290-304.